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 Abstract—Through the use of semi structured interviews with 
medical device software organizations it emerged that medical 
device software organizations are experiencing difficulties when 
following plan driven Software Development Life Cycles (SDLC), 
particularly in the area of requirements management. To attempt 
to resolve these issues an examination of the non-regulated 
industry was performed to determine if lessons learned there 
could be applied to the development of medical device software. 
This examination revealed that agile methods are being widely 
adopted in the non-regulated software industry. To learn if agile 
methods could be adopted when developing medical device 
software a mapping study was performed which looked for 
instances of where agile methods have been used in regulated 
industries and where they have been adopted, to what success. 
This mapping study revealed that incorporating agile practices 
with the existing plan driven SDLC is the most favourable choice 
for medical device software organizations. This research aims to 
develop a SDLC which has a foundation of a plan driven SDLC 
which incorporates agile practices which can be followed when 
developing regulatory compliant software. 
 
Index Terms—Medical Device Software, Safety Critical, V-
Model, Agile, FDA, AV-Model 
I.  INTRODUCTION  
Medical device software, as with most other safety critical 
software, must be developed in accordance with the regulatory 
requirements of the region into which the software is being 
marketed. Regulatory requirements are in place to ensure the 
safe and reliable functioning of the software. For the purpose 
of this paper, we will be focusing on developing medical 
device software which must be compliant with the Federal 
Drugs Administration (FDA) regulations for use in the United 
Sates (US). 
Medical device software developers typically develop 
software in accordance with a plan driven sequential Software 
Development Lifecycle (SDLC), such as the V-Model [1], as it 
appears to be the ―best fit‖ with regulatory requirements [2]. 
To gain a deeper insight into the challenges experienced when 
developing medical device software we performed semi-
structured interviews with 7 medical device software 
organizations. An expected finding of the interviews was that 
regulatory controls introduce a large amount of overhead when 
developing medical device software. Each of the organizations 
identified that the process of introducing a change once 
development has begun results in revisiting stages of 
development and therefore increases costs. Based upon the 
findings of the interviews we began to look at software 
development methods that are better suited to accommodating 
requirements changes 
In the non-regulated software development industry, there 
is a move away from plan driven SDLC‘s towards agile 
software development methodologies and practices [3]. Agile 
methodologies and practices appear to offer a ―silver bullet‖ to 
problems associated with following a plan driven SDLC such 
as being inflexible and unable to accommodate changes [4, 
p.41]. Evidence exists which reports significant benefits being 
gained within the non-regulated software development 
industry from utilising agile practices, such as reduced costs, 
reduced time to market and increased quality [5]. Despite this, 
the rate of adoption of agile practices amongst medical device 
software development organizations is low. There is no 
conclusive reason for this; however, a number of reasons have 
been cited. One such reason is that agile practices appear to be 
contradictory to regulatory requirements [6]. For example, 
medical device software organizations are required to submit 
extensive documentation to prove their device is safe for use 
in order to achieve regulatory approval, yet one of the four 
values of the agile manifesto states, ―working software over 
comprehensive documentation‖ [7]. This would appear to 
suggest that following agile methods would not produce the 
necessary documentation required when seeking regulatory 
approval. Even though agile software development practices 
are often perceived to be contradictory to regulatory 
requirements, case studies have emerged from medical device 
software development organizations which have successfully 
adopted agile practices and received regulatory approval. For 
example, Abbott Diagnostics integrated agile practices with 
their plan driven SDLC on a development project and reported 
a cost saving of between 35% and 50% when compared to 
following a plan driven software development lifecycle [8].  
Lightweight methods such as the Crystal Family of 
methodologies do appear to offer guidance for the 
development of safety critical software. Crystal methods place 
the agile values secondary to the primary focus of the software 
which can be: People, Interactions, Community, Skills, Talents 
and Communications. The Crystal methods use a coloured 
weighting scheme based upon criticality and objectives to 
determine which ―colour‖ to use i.e. Crystal Clear, Crystal 
Orange etc. [9]. This would appear to be of value to the 
development of medical device software; however, the crystal 
methods do not take into account regulatory requirements and 
therefore can be difficult to wholly follow when developing 
regulatory compliant software. 
This paper attempts to answer the following research 
questions: 
1) Can agile practices be used to develop medical device 
software? 
2) If agile practices can be used to develop medical device 
software, how must be incorporated with the existing lifecycle 
in order to meet regulatory requirements? 
 To answer these research questions, semi structured 
interviews and a mapping study were performed. This paper 
outlines the interviews conducted with medical device 
software organizations as part of this research into the field of 
medical device software development. In our  discussion on 
the SDLC which medical device software organizations 
currently adopt (Section II-C), we note that prior research has 
found that the V-Model is the most widely used [1]. Following 
this, we carried out a Mapping Study into the use of agile 
software development in medical device software 
development industries and propose the Agile V-Model (AV-
Model) as a SDLC for use in the medical device industry.  It 
aims to provide medical device software developers with the 
structure to follow a plan driven approach whilst reaping the 
benefits of utilising agile practices. 
II. MEDICAL DEVICE SOFTWARE DEVELOPMENT 
A. Software Development Techniques 
 Medical devices marketed for use within the USA must 
conform to the FDA CFR 21 Part 820 QSR [10]. Part 820.30 
Subpart C ―Design Controls‖ is specifically targeted at 
medical device software developers. The design controls cover 
the following areas: Design and Development Planning, 
Design Input, Design Output, Design Review, Design 
Verification, Design Transfer, Design Changes and Design 
History File. 
Whilst these stages appear to follow each other 
sequentially, the FDA does not dictate the use of a sequential 
SDLC such as the Waterfall Model to complete these stages. 
The GPSV states ―this guidance does not recommend any 
specific life cycle model or any specific technique or method”.  
B. Use of the V-Model in the Medical Device Industry 
Despite not dictating a SDLC to follow, medical device 
software development organizations typically follow the V-
Model [11]. It was first presented in 1991 at the NCOSE 
symposium [12] and is a variation on a SDLC which Royce 
presented which later became known as the Waterfall Model 
[13]. The V-Model identifies that there are different types of 
testing such as modular testing and integration testing [14]. 
The V-Model shows the relationship between the two sides of 
the development process. This relationship is used to 
determine whether the stage has been completed successfully. 
If a problem occurs during the verification or validation of any 
one stage, then the opposite stage on the ―V‖ must be revisited 
and if necessary reiterated [15]. Essentially, the testing of a 
product is planned in parallel with the corresponding phase of 
development. This method of developing software eases the 
process of achieving traceability. The FDA mandates that 
traceability be an integral part of a development process [16]. 
Therefore the V-Model is perceived to be the ―best fit‖ with 
the regulatory requirements. While it may be the best fit, in 
practice the V-Model presents the same problems that are 
associated with utilizing any sequential plan driven SDLC. 
Royce, who presented the Waterfall model stated there are 
inherent problems associated with following a sequential 
lifecycle [13]. For example, as requirements are fixed at such 
an early stage, it can be very difficult to introduce a change in 
requirements once the project is underway. Also, it can be 
very difficult to capture all of the requirements at such an early 
stage of a project [4]. In addition to this, any changes 
introduced once a project is underway can create cost and 
budget overruns [17].  
C. AAMI TIR 45:2012 
In October 2012, the Association for the Advancement of 
Medical Instrumentation (AAMI) released a Technical 
Information Report (TIR) entitled TIR 45:2012--Guidance on 
the use of agile practices in the development of medical device 
software [18]. The committee which developed the TIR 
consisted of industry experts and FDA staff. The AAMI 
recognised the shift in the non-regulated software development 
industry towards more agile practices and the evidence 
presented from successful adoption of agile practices in 
medical device software development organizations. However, 
they identified that the available information which details the 
use of agile practices in the development of medical device 
software was hard to understand and the objective of the TIR 
is to provide clear guidance on which agile practices are suited 
to the development of medical device software. The TIR also 
provides recommendations for complying with international 
standards and FDA guidance documents when using agile 
practices to develop medical device software. However, this 
document is at a high level and only addresses the use of a 
limited number of agile practices when developing software in 
accordance with IEC 62304 which in itself does not provide 
guidance for the development of standalone software [19].  
III. AGILE IN MEDICAL DEVICE SOFTWARE DEVELOPMENT 
Research to date has revealed that the non-regulated software 
development industry is benefiting from moving towards more 
agile processes [8]. However, the medical device software 
development industry has not reaped the same benefits. This 
research aims to establish why these successes have not been 
replicated to great extent. This research is being performed 
following a Pragmatic Approach and in collaboration with 
medical device software organizations. As this research aims 
to overcome the challenges faced by these organisations it is 
therefore prudent to learn first-hand what the challenges 
experienced are. This interviews detailed do not aim to seek 
statistical generalisation, but rather to seek theoretical 
generalisation [20].  
A. Semi-Structured Interviews 
To gain a deeper insight into the challenges faced by 
medical device software development organizations Semi-
Structured interviews were performed in accordance with 
Wengraf [21]. The interviews performed are known as Semi-
Structured Depth Interviews (SSDI). SSDI are broken into two 
classifications, Heavily Structured Depth Interviews and 
Lightly Structured Depth Interviews. The degree of the 
structuring is determined by the degree to which the questions 
and interventions are pre-prepared by the researcher. In 
accordance with Wengraf the interviews were broken in to 
four elements: Research Purposes (RP), Central Research 
Questions (CRP), Theory Questions (TQ) and Interview 
Intervention (II)\Interview Questions (IQ).  
The RP is the motivation behind the research being 
conducted. For this research, the RP is to gain a deeper insight 
into difficulties experienced when developing medical device 
software. The CRQ is the primary question(s) to which 
answers are being sought as a result of the interview being 
conducted. The TQ are high level questions. These questions 
are not asked directly to the interview participant. TQ are used 
to formulate the actual questions that will be asked of the 
participant. II/IQ is what is actually asked of the participant 
during the interview. The information gleaned from the 
responses is compiled to answer the TQ which in turn answer 
the CRQ which ultimately supports the RP. 
The results of the interviews were analyzed in accordance 
with Wengraf‘s  Interview Material to Answers to Theory 
Questions to an Answer to the Central Research Question (IM-
ATQ-ACRQ) model [21]. Whilst the CRQ > TQ > IQ/II 
model utilizes a top down approach, the IM-ATQ-ACRQ 
model utilizes a bottom up approach to determine the answer 
to the central research question. This method was used as it 
complimented the method employed for the creation of the 
interview questions i.e. RP > CRQ > TQ > IQ/II. The results 
were also analyzed in accordance with Miles and Huberman‘s 
[22] method of analyzing qualitative data i.e. Data Reduction, 
Data Display and Conclusion Drawing & Verification.  
Each of the organizations involved in the interviews 
identified that a major problem they experience is 
accommodating changes once development has begun. To 
accommodate changes a number of stages may need to be 
revisited, having a knock on effect of increasing rework and 
therefore increasing cost. When asked in the interviews how to 
resolve the problems associated with changing requirements a 
number of responses were given. One organization suggested 
the establishment of an incubation period prior to the 
requirements analysis stage. This incubation period would 
allow the customer time to consider all potential features they 
wished to include in the software and ideally removing the 
need for a change to be implemented once the project has 
begun. Another organization suggested placing greater 
emphasis on up-front planning and again making sure all of the 
necessary requirements were captured. One organization 
suggested ―placing manners on the customer‖ and preventing 
them from introducing a change once development has begun.  
Each of these suggestions has their own merit, however 
these are proactive steps, none of the organizations were able 
to suggest a reactive response to when a requirements change 
was unavoidable. Current plan driven SDLCs are rigid and 
therefore have difficulty accommodating a change. Typically, 
when a change is introduced a number of stages need to be 
revisited to accommodate the change. This can require a lot of 
rework therefore increasing cost and development time. As a 
result a software development method which can 
accommodate changes once development has begun could 
bring benefit to medical device software organizations. 
B. Mapping Study 
While the interviews performed identified the challenges 
faced by medical device software development organisations, 
they did not answer the question as to how these problems can 
be overcome. As discussed agile methods would appear to 
solve the problems mentioned; however this needed to be 
confirmed. To understand why the medical device software 
development industry has not benefited from adopting agile 
practices this paper focuses on the following research 
questions. 
To answer these questions, a Mapping Study was 
performed. This Mapping Study was conducted in accordance 
with guidelines from Petersen et al. [23]. From an overall 
perspective, this process involved three main steps: 1. 
planning the review, 2. conducting the review and 3. reporting 
the review. 
By approaching the review in such a systematic manner 
and demonstrating the rigor applied to each step, we build a 
higher level of confidence in our conclusions. We developed a 
protocol containing a full breakdown of the research approach. 
The Mapping Study quickly showed there to be limited 
published material in this specific area. In order to progress 
our investigation, we widened our review to cover regulated 
safety-critical software development in general. Due to 
similarities in the domains, lessons learned from within other 
regulated safety critical industries, such as Avionics and 
Automotive, software development can potentially be applied 
to the development of medical device software. We 
specifically included the following priori assumption to make 
any bias clearly identifiable: 
TABLE 1 LITERATURE SOURCES 
SOURCE URL 
ACM http://portal.acm.org/portal.cfm 
Compendex http://www.engineeringvillage2.org 
IEEE http://ieeexplore.ieee.org/Xplore 
INSPEC http://www.theiet.org/inspec 
Science 
Direct 
http://www.sciencedirect.com 
Web of 
Science 
http://apps.isiknowledge.com 
Misc. Book Sections, Thesis, Industry Reports, 
Websites 
 
Some practices/aspects of agile software development do not 
adequately support all the requirements of the regulations for 
safety-critical software development, such as those laid down 
by the US regulatory bodies. 
The main tasks described in our protocol are: identifying data 
sources, building search strings, performing pilot search, 
adjusting search criteria, exporting results for citation 
management, applying inclusion/exclusion criteria, quality 
assessment, data extraction and data synthesis. While we 
found this a very positive approach in terms of providing a 
clear and unambiguous path through the literature, other 
important contributions were available from industry sources 
such as non-academic books, reports and other online 
resources. Our opinion is that this grey literature assists in 
addressing publication bias.  Therefore, it was included in our 
study. 
C. Search Sources and Strings 
Taking the Mapping Study guidelines as a starting point 
and looking at other published Mapping Studies and 
Systematic Literature Reviews (SLR) [24-27], we used the 
electronic sources noted in Table 1. An important lesson in the 
practice of searching electronic databases, is that each 
database search engine is different as highlighted by Brereton 
et al. [28].  
The specific search strings were formed following the 
Population, Intervention, Comparison, Outcomes and Context 
(PICOC) criteria suggested by Petticrew and Roberts [29]. The 
generic query we used can be written as follows: 
 “any document containing the phrase „medical device‟ or 
„embedded software‟ or the word stem „regulat‟ AND any of 
the following phrases („software development‟, „software 
process‟, „software life-cycle‟, „manufacturing software‟) AND 
containing any of the following words/phrases („agile‟, 
„scrum‟, „XP‟, „extreme programming‟, „crystal‟, „lean‟.). 
D. Inclusion and Exclusion Criteria 
The inclusion criteria were: 
- Peer Reviewed Research Papers; 
- Grey Literature from experienced practitioners; 
- Relevant to safety-critical software development; 
- Focus on agile practices. 
The exclusion criteria included: 
- Non-English language; 
- Content too general (for example a high level review 
of agile practices); 
- Duplicated work; 
- Off Topic (Does not concentrate on expected subject 
matter) 
E. Quality Attributes 
As described by Petersen et al. [23], an integral part of a 
Mapping Study is to assess the quality of the primary studies. 
This aids in determining the relevant importance of a study by 
capturing, for example: 
- The possible effects of bias; 
- The importance of a study in the body of literature; 
- The relevance to your particular research questions(s). 
In order to determine the value of each paper, a series of 
questions were asked of each one (Table 2) and the answer 
recorded on the data extraction sheet. Following this, we 
added an overall rating [1-poor to 5-excellent] to each entry.  
This step had particular importance as many of the papers 
were not empirically based. The average overall rating was 
3.46. Of the 26 papers identified, 2 was the lowest rating 
given. 
F. Data Extraction 
Following the technique used by Dyba and Dingsor [30] 
for citation management, the results of the searches were 
exported. The publications underwent an initial 
inclusion/exclusion analysis. This was carried out by the 
primary reviewer and validation performed by the secondary 
reviewers.  
A two-step approach to the inclusion/exclusion was carried 
out. First, papers were excluded on the basis of their title and 
abstract. All remaining papers were then read in full and 
irrelevant papers were excluded. The remaining entries formed 
the basis of the review. The relevant data was extracted into 
Microsoft Excel Spread sheet (data extraction template), 
where subsequent information, such as inclusion/exclusion 
justification, quality attributes and a short note on the 
limitations of each publication, were recorded. From an initial 
count of 193 results, the data set was reduced to 64 in the first 
TABLE 2 QUESTIONS USED TO SOLICIT QUALITY OF PAPER 
Does the study predominantly relate to software 
development with a safety critical regulated setting? 
Which particular agile methodology does it look at in 
depth? 
Does it report on real-life case studies where an agile 
methodology was used? 
Does the study find in favour of the applicability of agile 
software development methodologies within a safety-
critical, regulated setting? 
What ‘flavour’ of agile does the study promote?  
- Agile (the practices of a single agile methodology) 
- Agile – Agile (a combination of different agile 
methodologies) 
- Agile – Planned (A combination of agile and traditional 
methodologies) 
 - None (it does not recommend agile methodologies) 
 
TABLE 3 SEARCH RESULTS SUMMARY 
SOURCE Count 1
st
 Review 
2
nd
 
Review 
ACM 72 18 6 
Compendex 35 11 6 
IEEE 20 11 7 
INSPEC 15 5 2 
Science Direct 29 4 0 
Web of Science 5 0 0 
Misc. 17 15 5 
Total 193 64 26 
 
review, and then to 26 in the second review.  The 26 results 
spanned the years 2002-2012. Of experience reports published 
at international conferences (50%), only 6 were classified as 
empirical research papers – 5 case studies and 2 surveys. This 
is indicative of the lack of empirical research in this specific 
field. 
G. Data Synthesis 
While the Mapping Study detailed here looked at regulated 
embedded software development in general, we have a special 
interest in medical device software development. The 
Mapping Study found that 11 papers (42%) report from a 
medical device perspective. This acts as evidence that agile 
practices can be followed when developing medical device 
software. All of the organizations which reported using agile 
practices to develop medical device software, highlighted that 
using them had a positive impact within their development 
project. The agile methodologies which appeared most 
throughout the literature were XP and Scrum. 
One of the areas we were interested in investigating was 
the ‗flavour‘ of agile being adopted/trialled in this domain. 
The Mapping Study determined whether full standalone agile 
methodologies (Agile), a combination of different agile 
methodologies (Agile-Agile), or utilising agile in conjunction 
with traditional plan driven development techniques (Agile-
Planned) was being favoured. The results show that almost 
46% of the papers reported on the adoption or trials of Agile-
Planned usage, with 19% adopting Agile, a further 19% 
adopting Agile-Agile and the remaining 16% reported no 
preference. Therefore, our Mapping Study provides evidence 
that a hybrid model incorporating agile with plan driven 
methodologies is the most favourable option when developing 
medical device software. 
IV. TAILORED SOFTWARE DEVELOPMENT LIFECYCLE 
As shown in the Mapping Study, there is still a limited 
amount of publicly available information detailing where 
medical device organizations have utilised agile practices. 
Despite this, there is evidence to suggest [8, 31] that medical 
device software development projects can benefit from 
embracing agile practices. Whilst the Mapping Study revealed 
that agile practices can be used in the development of medical 
device software, it also revealed that a combination of Agile 
and Planned appears to be more suited to the development of 
medical device software. Through the Mapping Study, it 
emerged that there is currently no single SDLC which medical 
device software developers can follow when developing 
medical device software which combines agile and plan driven 
techniques. Instead, organizations employing agile are 
tailoring their existing lifecycles to incorporate agile practices. 
This method may be suited to large organizations with 
multiple projects that can trial agile practices in a project to 
determine whether they appropriate. Smaller medical device 
software developers may only be working on a single project 
at a time and cannot risk trialling agile on their only project. 
The hybrid SDLC proposed in this paper aims to provide 
medical device software development organizations, 
regardless of size or maturity, guidance on the development of 
safe and reliable medical device software which is regulatory 
compliant, whilst reaping the benefits associated with utilising 
agile practices. 
A. Development of Agile V-Model 
The process of developing the Agile V-Model is broken 
into clear distinct phases: 
1. Selection of foundation plan driven SDLC; 
2. Preparing for inclusion of agile practices into plan 
driven SDLC; 
3. Identification of applicable agile practices to the 
development of medical device software. 
1) Selection of foundation plan driven SDLC: When 
selecting the foundation of the hybrid SDLC, a number of plan 
driven SDLCs were examined. The conclusion was made that 
the V-Model is the most appropriate model on which to build 
the hybrid SDLC. The reasons for choosing the V-Model are: 
 Medical device software organizations typically follow the 
V-Model to develop medical device software. As a result, 
they are already familiar with the structure and phases of 
the V-Model and would be more willing to adopt a hybrid 
model based upon a SDLC with which they are familiar. 
 Medical device software organizations may have received 
regulatory approval to follow the V-Model when 
developing medical device software. If these organizations 
move to a completely different SDLC, they may need to 
re-apply for regulatory approval for the new SDLC. This 
may be a barrier as organizations could be reluctant to 
undergo regulatory approval again. 
 Whilst none of the regulatory requirements or development 
standards mandate the use of the V-Model, it appears to be 
the best fit with regulatory requirements, as it guides 
organizations through the process of producing the 
necessary deliverables required to achieve regulatory 
conformance.  
2) Preparing for Inclusion of Agile practices into plan 
driven SDLC: Each of the agile methodologies advocates 
iterative software development. Each of the sequential plan 
driven SDLCs suffer the problem of being rigid and inflexible 
to change. With iterative techniques, changes can be 
introduced to a development project without needing to revisit 
a number of other stages of the SDLC. However, to 
incorporate iterative techniques, the process of ―Risk 
Identification‖ needs to be added to the model. Risk 
Identification involves analysing the project, dividing it into 
iterations and identifying the iterations which pose the most 
risk to the project. The iterations that pose the most risk are 
then performed as early as possible in the project. Once risk 
identification is added, each of the stages of the V-Model is 
assessed to determine which stages could be performed 
iteratively. As a result, all of the stages of the development 
lifecycle are divided into two categories: stages that can be 
performed iteratively and stages that can only be performed in 
a single pass. For example, the FDA requires the device 
manufacturers to submit high level requirements prior to 
beginning development.  Therefore, this can only be done 
once. Also, the process of achieving regulatory approval can 
only be sought when a device is completed and the acceptance 
tests have all passed. Therefore, this can only be completed 
once. However, other stages such including ―Software 
Architecture Design‖ and ―Unit Implementation‖ can be 
performed iteratively.   
3)  Identification of applicable agile practices to the 
development of medical device software; To identify agile 
practices applicable to the development of medical device 
software, each of the agile methodologies - Scrum, XP, 
DSDM and Crystal clear - were examined. Based upon this 
examination, 59 agile practices were identified. A comparison 
between these 59 practices and the appropriate regulations and 
standards was performed. This comparison revealed that none 
of the 59 identified practices contradict regulations or 
development standards. However, despite these practices not 
being contradictory to regulations or standards, their 
applicability to the development of medical device software 
development remains unclear. To determine the level of 
applicability, based upon the findings of the Map ping Study, 
13 practices were identified as being applicable to the 
development of medical device software. These practices have 
been selected based on the fact that they have been 
successfully adopted in medical device software organisations 
developing regulatory compliant software [32]. These 
practices include iterative development, use cases/user stories 
and test driven development. These 13 practices were then 
mapped to the appropriate stage of the SDLC. A problem 
associated with following a plan driven SDLC, is the emphasis 
placed on up-front planning. This can result in a project 
suffering if a change is introduced after development has 
begun. Using iterative development, detailed requirements can  
be easily revisited and if a change in requirements is made, 
this change can be accommodated in an upcoming iteration. 
Whilst only 13 practices have been identified to date, we 
are continuing our validation on the remaining 46 practices. 
On-going research will determine how many of the remaining 
practices are applicable to medical device software 
development and these practices will be mapped to the model 
were appropriate. Some of the remaining practices to be 
examined for applicability include, Continuous Improvement, 
Definition of Done and Test Driven Development.    
B. Hybrid Model 
Figure 1 shows the AV-Model. Each of the 13 practices 
identified through the Mapping Study is mapped to the 
appropriate stage of development such as ―On Site Customer‖, 
―Iterative Development‖, ―Use Cases / User Stories‖. Whilst 
practices have been mapped to specific stages, it does not 
preclude the use of the practice at another stage of 
development. For example, Fig. 2 shows the use of ―User  
 
Stories‖ and ―Use Cases‖ at the ―Requirements Specification‖ 
stage. These can also be used in the ―Architectural Design‖ 
stage. Two identified applicable practices not shown in the 
model are ―Collocated Teams‖ and ―Self Organising Teams‖. 
These are not displayed graphically on the model as these 
practices do not relate to a specific stage of the development 
lifecycle.  Rather, they are related to team structure.  
C. Model Validation 
The objective of the development of this model is to 
resolve problems associated with following a plan driven 
software development lifecycle, whilst reaping the benefits of 
utilising agile practices. As the model is currently under 
development it has not yet been fully validated. However, 
there will be two stages in the process of validation: Expert 
Opinion and Implementation. The development of the AV 
model is an iterative one. Once a stage of validation is 
complete feedback will be applied and the model will proceed 
to the next stage of validation. Feedback will be obtained 
through the use of a survey instrument with open ended 
questions. 
1) Expert Opinion: Once the model has received 
validation from industry it will be distributed to experts in the 
field of medical device software development. Agreement has 
already been made with members of the IEC 62304 committee 
and members of the TIR 45:2012 committee to provide 
validation of the model. By eliciting this form of feedback the 
model aims to gain acceptance in the standards community. 
2) Implementation: Once the model has undergone the 
Expert Opinion validation, it will be adopted by a medical 
device software development organization. A medical device 
software organization has agreed to implement the model once 
it is completed and passed through each of the steps of 
validation. 
V. RELATED WORK 
In [33] research is conducted that provides information as to 
how the avionics industry can benefit from adopting agile 
practices. In this research, the author investigates the 
regulatory constraints placed upon avionic software 
developers adhering to DO-178B [34] and whether or not XP 
can be used in this domain. The research revealed that XP 
could not practically be used in the case study, but the author 
FIGURE 1 THE AV-MODEL 
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surmises that avionics software development could benefit 
from adopting agile practices. In [33] the authors provide 
information as to how employing XP can be beneficial in areas 
such as requirements managements and change management. 
However, the authors also discuss that for XP to be a success 
in such a project there are prerequisites such as early customer 
involvement.   
In Vanderleest and Butler [35] a mapping is performed 
between Agile practices and the development practices as part 
of DO-178B. This mapping demonstrates the ability to utilize 
agile practices in the development of avionics software. 
However, Vanderleest identifies that there has not been a large 
amount of research in the area of using Agile in avionics and 
calls for other researchers to establish collaboration to research 
the area further.  
Manhart and Schneider [36] present a case study of the 
adoption of agile practices in the Daimler Chrysler software 
engineering department. Within this study the organization 
examined the possibility of adopting a full Agile methodology, 
but found that a tailored framework suited there development 
requirements. To that end, elements of agile i.e. test first 
process, were integrated into a traditional process 
improvement model. This research did not focus on any one 
agile methodology to extract practices from, but rather took a 
wider view of all of the agile practices. 
This related work shows that other regulated industries are 
examining the possibility of utilizing agile practices to 
overcome the challenges associated with following plan driven 
SDLCs. It also shows that where agile practices have been 
used they have been most successful when incorporated with a 
plan driven approach.  
VI. CONCLUSIONS 
Through semi structured interviews it was revealed that 
medical device software organizations are experiencing 
difficulties when following a plan driven SDLC in areas such 
as requirements management. To overcome these problems an 
examination of other development techniques was performed. 
This examination revealed that agile methods could potentially 
overcome the challenges associated with following a plan 
driven SDLC. To that end, through the conduction of a 
Mapping Study, it has been shown that medical device 
software development organizations can develop regulatory 
compliant software whilst utilising agile practices.  The 
Mapping Study also revealed that, where adopting agile has 
proved successful, the existing lifecycle was tailored to 
accommodate agile practices rather than wholly embracing a 
complete agile methodology such as Scrum or XP. 
Although agile practices have been successfully adopted in 
medical device software development organizations, this 
success has not been replicated to a great extent. One potential 
reason for this is the reluctance of medical device software 
developers to move away from tried and tested techniques 
such as the V-Model. An additional reason may also be that 
medical device software development organizations have 
already achieved regulatory approval to use their current 
SDLC and, if they moved to a completely different SDLC, 
they may need to submit for approval once more. The hybrid 
model, being based upon the V-Model, will remove this need.  
This paper proposes a hybrid SDLC known as the AV-
Model, which combines both agile and plan driven 
development practices can follow when developing regulatory 
compliant software. This SDLC has been developed to resolve 
some of the problems, such as inflexibility, which medical 
device software development organizations are experiencing 
when following a plan driven SDLC. Whilst the development 
of this model is on-going, medical device software 
development organizations can benefit from the results of this 
research to date and it is expected that the model will grow to 
incorporate additional applicable practices. The remaining 
applicable practices will be identified through collaborations 
with medical device software development organizations. 
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